NITYR (Cycle Pharmaceuticals Ltd.)


Welcome to the PulseAid listing for the NITYR drug offered from Cycle Pharmaceuticals Ltd.. This 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cycle Pharmaceuticals Ltd.
NON-PROPRIETARY NAME: Nitisinone
SUBSTANCE NAME: NITISINONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC],Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-07-26
END MARKETING DATE: 0000-00-00


NITYR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNITYR from Cycle Pharmaceuticals Ltd.
LABELER NAME: Cycle Pharmaceuticals Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2017-07-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70709-000_759533f6-e30f-4b1d-a17f-9d0f681d671c
PRODUCT NDC: 70709-000
APPLICATION NUMBER: NDA209449

Other NITISINONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cycle Pharmaceuticals Ltd.NITYR
SWEDISH ORPHAN BIOVITRUM AB (PUBL)Orfadin
Swedish Orphan Biovitrum AB (publ)ORFADIN